BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 33926377)

  • 1. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
    Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
    BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19.
    Yang K; Xing MY; Jiang LY; Cai YP; Yang LL; Xie NN; Chen J; Wang WX; Wang L; Zhu JL; Zhang DY; Ruan QR; Song JX
    Curr Med Sci; 2021 Feb; 41(1):39-45. PubMed ID: 33582903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine storm in severe COVID-19 pneumonia.
    Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
    J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An elevated HScore is associated with poor clinical outcomes in COVID-19.
    Benavente R; Peña C; Cid A; Cabello N; Bustamante P; Álvarez M; Henríquez E; Soto A; Rubilar E
    Rev Med Chil; 2023 Feb; 151(1):15-22. PubMed ID: 37906742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.
    Dimopoulos G; de Mast Q; Markou N; Theodorakopoulou M; Komnos A; Mouktaroudi M; Netea MG; Spyridopoulos T; Verheggen RJ; Hoogerwerf J; Lachana A; van de Veerdonk FL; Giamarellos-Bourboulis EJ
    Cell Host Microbe; 2020 Jul; 28(1):117-123.e1. PubMed ID: 32411313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe COVID-19-associated hyperinflammatory syndrome versus classic hemophagocytic lymphohistiocytosis: similarities, differences, and the way forward.
    Yadav G; Malhotra H; Mehta P; Sachu R; Rizvi I; Bharti VR; Kumar M; Kumar N; Ali W; Verma SP; Puri B; Dandu H
    J Investig Med; 2023 Mar; 71(3):244-253. PubMed ID: 36803041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].
    Alfaro-Murillo A; Lazo-Paéz G
    Rev Chilena Infectol; 2021 Apr; 38(2):271-278. PubMed ID: 34184718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
    Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
    Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.
    Schnaubelt S; Tihanyi D; Strassl R; Schmidt R; Anders S; Laggner AN; Agis H; Domanovits H
    Medicine (Baltimore); 2021 Mar; 100(12):e25170. PubMed ID: 33761694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.
    Brikman S; Bieber A; Dori G
    Isr Med Assoc J; 2020 Aug; 22(8):505-513. PubMed ID: 33236584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the HScore as a predictor of disease outcome in patients with COVID-19.
    Bordbar M; Sanaei Dashti A; Amanati A; Shorafa E; Mansoori Y; Dehghani SJ; Molavi Vardanjani H
    BMC Pulm Med; 2021 Oct; 21(1):338. PubMed ID: 34715834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality.
    Ardern-Jones MR; Stammers M; Phan HT; Borca F; Koutalopoulou A; Teo Y; Batchelor J; Smith T; Duncombe AS
    Clin Med (Lond); 2021 Sep; 21(5):e543-e547. PubMed ID: 34389636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.
    Chen J; Wang X; He P; Li Y; Si M; Fan Z; Chang X; Xie Q; Jiao X
    J Med Virol; 2016 Mar; 88(3):541-9. PubMed ID: 26287378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
    Yongzhi X
    Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients.
    Rivière S; Galicier L; Coppo P; Marzac C; Aumont C; Lambotte O; Fardet L
    Am J Med; 2014 Nov; 127(11):1118-1125. PubMed ID: 24835040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of 47 secondary hemophagocytic lymphohistiocytosis patients complicated with capillary leak syndrome.
    Man C; Wang M; Yin G; Huang J; Cheng W; Wu X; Liu L; Gao X; Wang J; Tian T; Duan L; Xu J; Qiu H
    Int J Hematol; 2021 Feb; 113(2):263-270. PubMed ID: 33037588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue.
    Kan FK; Tan CC; Von Bahr Greenwood T; Khalid KE; Supramaniam P; Hed Myrberg I; Tan LH; Henter JI
    Clin Infect Dis; 2020 May; 70(11):2247-2255. PubMed ID: 31188423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
    Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
    BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis.
    Grangé S; Buchonnet G; Besnier E; Artaud-Macari E; Beduneau G; Carpentier D; Dehay J; Girault C; Marchalot A; Guerrot D; Tamion F
    Crit Care Med; 2016 Nov; 44(11):e1045-e1053. PubMed ID: 27441901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.